ReWalk Robotics Hopes to Raise $50M in IPO
From Boston Herald:
A company with U.S. headquarters in Marlborough that was recently awarded FDA approval to sell its robotic exoskeletons for paraplegics plans to raise $50 million in an IPO this week, possibly on Friday.
Israeli-based ReWalk Robotics is planning to sell 3.5 million shares for between $14 and $16 each, which puts it at the low end of the 13 local health care companies which have gone public since the beginning of the year, more than any other year in history. Most of those have been biotech companies, however, making ReWalk the first robotics-focused company to do so in at least a couple of years... (cont'd)
Comments (0)
This post does not have any comments. Be the first to leave a comment below.
Featured Product
Palladyne™ IQ - Unlocking new frontiers for robotic performance.
Palladyne™ IQ is a closed-loop autonomy software that uses artificial intelligence (AI) and machine learning (ML) technologies to provide human-like reasoning capabilities for industrial robots and collaborative robots (cobots). By enabling robots to perceive variations or changes in the real-world environment and adapt to them dynamically, Palladyne IQ helps make robots smarter today and ready to handle jobs that have historically been too complex to automate.
